Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07288749 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction.

Study acronym: GLID-HF
StatusNot Yet Recruiting
PhasePhase 3
Started2026-01-01
View on ClinicalTrials.gov ↗
197 trials monitored
See 2 trials at risk
4,247 trials monitored
See 176 trials at risk
2,082 trials monitored
See 101 trials at risk
1,854 trials monitored
See 95 trials at risk
Evaluating the safety and efficacy of glimepiride in patients with type 2 diabetes and chronic heart failure with reduced ejection fraction--a multicenter randomized controlled study.
Trial Details
NCT Number NCT07288749
Lead Sponsor Tongji Hospital
Collaborators: Shanghai Zhongshan Hospital, Nanjing Medical University, Second Xiangya Hospital of Central South University, Huaxi Hospital, Zhongnan Hospital, Xiangya Hospital, Beijing Anzhen Hospital, The First Affiliated Hospital of Air Force Medicial University, Chinese Academy of Medical Sciences, Fuwai Hospital, The First Affiliated Hospital of Zhengzhou University, First Affiliated Hospital of Xinjiang Medical University, Anhui Provincial Hospital, Southwest Medical University, First Hospital of China Medical University, Wuhan Central Hospital, Tianjin Medical University
Conditions Type 2 Diabetes Mellitus (T2DM), Chronic Heart Failure (CHF)
Enrollment 1,484 participants
Start Date 2026-01-01
Primary Completion 2030-12-31 (estimated)
Study Completion 2031-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-17